Drug Trial Radar · NCT07230834
Intravitreal (IVT) Pozelimab for Geographic Atrophy (GA) in Adult Participants
Last checked: Nov 20, 2026Latest source record: Aug 5, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
54
Planned (sponsor's estimate)
Start
Jan 19, 2026
Primary completion
Jul 3, 2028
Study completion Jul 3, 2028
Sponsor
- Lead sponsor
- Regeneron PharmaceuticalsRegeneron (REGN)
- Sponsor type
- Industry
- First posted
- Nov 17, 2025
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Randomized
- Model
- Sequential
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 50 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study is researching an experimental drug called pozelimab (called "study drug"). The study is focused on people with a condition where certain parts of the eye's retina stop working over time, which can make it harder to see. This is called geographic atrophy (GA). The aim of the study is to see how safe and tolerable the study drug is when used as an injection in the eye. The study is looking at several other research questions, including: * What side effects may happen from taking the study drug * How much study drug is in the blood and the fluid in the eye at different times * Whether the body makes antibodies against the study drug (which could make the drug less effective or could lead to side effects)
Conditions
- Geographic Atrophy (GA)
Interventions
PozelimabDrug
Administered per the protocol
Primary outcomes
What the sponsor says the trial is designed to measure.
- Occurrence of ocular Treatment-Emergent Adverse Event (TEAEs) in the study eyeTime frame: Through week 8
- Occurrence of ocular TEAEs in the study eyeTime frame: Through week 16
- Occurrence of systemic TEAEsTime frame: Through week 8
- Occurrence of systemic TEAEsTime frame: Through week 16
Locations
9 sites in 4 countries. Site status is shown where the registry gives one.
Colorado Retina Associates
Lakewood, Colorado · Recruiting
Ophthalmic Consultants of Boston
East Weymouth, Massachusetts · Recruiting
Austin Retina Associates
Austin, Texas · Recruiting
Retina Foundation of the Southwest
Dallas, Texas · Recruiting
Retina Consultants Texas
The Woodlands, Texas · Recruiting
Arensia Exploratory Medicine at the Research Institute of Clinical Medicine
Tbilisi, Georgia · Recruiting
Emanuelli Research and Development Center
Arecibo, Puerto Rico · Recruiting
ARENSIA Clinics SRL
Bucharest, Romania · Recruiting
Arensia Exploratory Medicine Clinic at Country Hospital Cluj-Napoca
Cluj-Napoca, Romania · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.